Hacker News new | past | comments | ask | show | jobs | submit login

I think it more a result of companies that synthesize the raw material being unwilling to whip up things like SARS variants, and it being quite difficult to figure something out like that from scratch. That may change or turn out to be incorrect, this is just my understanding at the moment.



Consider applying for YC's Spring batch! Applications are open till Feb 11.

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: